At-risk populations need to be priority beyond vaccine
At-risk populations need to be priority beyond vaccine By Patrick J. Kennedy An end to the pandemic is finally in sight. Both Pfizer and Moderna reported that their vaccine candidates are 95 percent effective, and subsequently received emergency use authorization from the FDA. Prioritizing the delivery of vaccines to people most at risk — including…
Read More “At-risk populations need to be priority beyond vaccine” »